{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:02:09Z","timestamp":1781812929656,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejca.2022.08.020","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T11:54:50Z","timestamp":1663415690000},"page":"158-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Maximal surgical tumour load reduction in immune-checkpoint inhibitor na\u00efve patients with melanoma brain metastases correlates with prolonged survival"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1514-1442","authenticated-orcid":false,"given":"Stefanos","family":"Voglis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1212-9875","authenticated-orcid":false,"given":"Valentina","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8652-0554","authenticated-orcid":false,"given":"Meltem","family":"G\u00f6nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Winklhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Mangana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2279-6906","authenticated-orcid":false,"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1748-174X","authenticated-orcid":false,"given":"Michael","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4639-4474","authenticated-orcid":false,"given":"Luca","family":"Regli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9408-3278","authenticated-orcid":false,"given":"Emilie","family":"Le Rhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian C.","family":"Neidert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.08.020_bib1","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.08.020_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000478050","article-title":"Treatment outcomes for metastatic melanoma of unknown primary in the new era: a single-institution study and review of the literature","volume":"93","author":"Utter","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2022.08.020_bib3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cncr.25634","article-title":"Prognostic factors for survival in melanoma patients with brain metastases","volume":"117","author":"Davies","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.08.020_bib4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.2004.08.140","article-title":"Determinants of outcome in melanoma patients with cerebral metastases","volume":"22","author":"Fife","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.08.020_bib5","first-page":"4655","article-title":"Recent trends in epidemiology of brain metastases: an overview","volume":"32","author":"Tabouret","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2022.08.020_bib6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol : Off J Euro Soc Med Oncol\/ESMO"},{"key":"10.1016\/j.ejca.2022.08.020_bib7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.annonc.2020.07.004","article-title":"ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee","volume":"31","author":"Keilholz","year":"2020","journal-title":"Ann Oncol : Off J Euro Soc Med Oncol\/ESMO"},{"key":"10.1016\/j.ejca.2022.08.020_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.08.020_bib9","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.08.020_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.08.020_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2021.07.028","article-title":"Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases","volume":"156","author":"Hilbers","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.08.020_bib12","doi-asserted-by":"crossref","first-page":"v534","DOI":"10.1093\/annonc\/mdz255.001","article-title":"Long-term outcomes from the randomized phase II study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets): anti-PD1 brain collaboration (ABC)","volume":"30","author":"Long","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.08.020_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1470-2045(12)70431-X","article-title":"Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial","volume":"13","author":"Long","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.08.020_bib14","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/S1470-2045(21)00545-3","article-title":"Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study","volume":"22","author":"Tawbi","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.08.020_bib15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.08.020_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11060-007-9510-4","article-title":"Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial","volume":"87","author":"Muacevic","year":"2008","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2022.08.020_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.410330605","article-title":"Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?","volume":"33","author":"Vecht","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejca.2022.08.020_bib18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3171\/jns.1996.84.5.0748","article-title":"Surgery versus radiosurgery in the treatment of brain metastasis","volume":"84","author":"Bindal","year":"1996","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2022.08.020_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11060-009-0061-8","article-title":"The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline","volume":"96","author":"Kalkanis","year":"2010","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2022.08.020_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejca.2021.07.032","article-title":"The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy","volume":"156","author":"Karschnia","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.08.020_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3171\/2016.8.GKS161359","article-title":"Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery","volume":"125","author":"Bian","year":"2016","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2022.08.020_bib22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2010.354","article-title":"Gender differences in melanoma survival: female patients have a decreased risk of metastasis","volume":"131","author":"Joosse","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.08.020_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000102028","article-title":"Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women?","volume":"215","author":"Hofmann","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.ejca.2022.08.020_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fsurg.2016.00030","article-title":"The current and future treatment of brain metastases","volume":"3","author":"Hardesty","year":"2016","journal-title":"Front Surg"},{"key":"10.1016\/j.ejca.2022.08.020_bib25","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s10143-020-01399-9","article-title":"Impact of additional resection on new ischemic lesions and their clinical relevance after intraoperative 3 Tesla MRI in neuro-oncological surgery","volume":"44","author":"Voglis","year":"2021","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.ejca.2022.08.020_bib26","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/j.ijrobp.2021.07.1565","article-title":"Combining laser interstitial thermal therapy with SRS improves time to progression for recurrent SRS-treated brain metastases","volume":"111","author":"Vaios","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2022.08.020_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11864-021-00912-6","article-title":"Role of laser interstitial thermal therapy in the management of primary and metastatic brain tumors","volume":"22","author":"Melnick","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ejca.2022.08.020_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95505-6","article-title":"Failure of diffusion-weighted imaging in intraoperative 3 Tesla MRI to identify hyperacute strokes during glioma surgery","volume":"11","author":"Voglis","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2022.08.020_bib29","article-title":"Tumour burden and efficacy of immune-checkpoint inhibitors","author":"Dall'Olio","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2022.08.020_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00259-018-4211-0","article-title":"Prognostic value of baseline metabolic tumor volume measured on (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in melanoma patients treated with ipilimumab therapy","volume":"46","author":"Ito","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ejca.2022.08.020_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/CJI.0000000000000258","article-title":"Clinical correlates of response to anti-PD-1-based therapy in patients with metastatic melanoma","volume":"42","author":"Davis","year":"2019","journal-title":"J Immunother"},{"key":"10.1016\/j.ejca.2022.08.020_bib32","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1158\/1078-0432.CCR-17-2386","article-title":"Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab","volume":"24","author":"Joseph","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.08.020_bib33","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1158\/1078-0432.CCR-19-3926","article-title":"Longitudinal monitoring of ctDNA in patients with melanoma and brain metastases treated with immune checkpoint inhibitors","volume":"26","author":"Lee","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.08.020_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jocn.2019.12.063","article-title":"Metastatic melanoma: surgical treatment of brain metastases - analysis of 110 patients","volume":"73","author":"McHugh","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ejca.2022.08.020_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejca.2020.02.021","article-title":"Survival of patients with advanced metastatic melanoma: the impact of MAP kinase pathway inhibition and immune checkpoint inhibition - update 2019","volume":"130","author":"Ugurel","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.08.020_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/neuros\/nyy146","article-title":"Preoperative vs postoperative radiosurgery for resected brain metastases: a review","volume":"84","author":"Prabhu","year":"2019","journal-title":"Neurosurgery"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492200507X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492200507X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:38:11Z","timestamp":1760733491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492200507X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":36,"alternative-id":["S095980492200507X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.08.020","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maximal surgical tumour load reduction in immune-checkpoint inhibitor na\u00efve patients with melanoma brain metastases correlates with prolonged survival","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}